Neurocrine Biosciences is a biopharmaceutical company based in San Diego, California, that discovers and develops medicines for neurological, psychiatric and endocrine conditions. Its products treat movement disorders such as tardive dyskinesia and Huntington's disease chorea, and it also offers treatments for endometriosis-related pain. The company serves patients and healthcare providers, mainly through specialty pharmacies and physicians in the United States, and it conducts research on disorders of the nervous and hormonal systems.
Neurocrine Biosciences Inc. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code N1BI34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #776 of 1455 on the B3 Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendFair
50/100
Mixed trend against its averages.
See the numbers →
Above 200-day average3.3%
From 52-week high-14.4%
MomentumWeak
43/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-11.9%
6-month return24.0%
12-month, skipping last month-6.4%
Stability (higher is calmer)Fair
61/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)33.8%
Worst drawdown, 1 year (smaller is calmer)-25.1%
LiquidityWeak
38/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.06M BRL
Zero-volume days40.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 31.51 – 45.78Daily closes, split-adjusted
Signals
50-day average38.05
200-day average37.95
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.77
Technical summary
Daily
Bullish
10 bullish · 1 neutral · 5 bearish
Weekly
Bullish
8 bullish · 1 neutral · 3 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
36.17
Bullish
EMA 10
36.86
Bullish
SMA 20
36.31
Bullish
EMA 20
36.76
Bullish
SMA 50
38.05
Bullish
EMA 50
37.96
Bullish
SMA 100
40.54
Bearish
EMA 100
38.76
Bullish
SMA 200
37.95
Bullish
EMA 200
38.54
Bullish
Oscillators (daily)
RSI (14)
65.49
Neutral
MACD (12, 26)
-0.21
Bearish
Momentum (12)
7.93
Bullish
Stochastic %K (14)
86.28
Bearish
Williams %R (14)
-13.72
Bearish
CCI (20)
207.2
Bearish
Pivot points (classic, last session)
S3
38.35
S2
38.53
S1
38.87
Pivot
39.05
R1
39.39
R2
39.57
R3
39.91
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
